» Articles » PMID: 26137103

Cordycepin Induces Apoptosis and Autophagy in Human Neuroblastoma SK-N-SH and BE(2)-M17 Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2015 Jul 3
PMID 26137103
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cordycepin, also termed 3'-deoxyadenosine, is a derivative of the nucleoside adenosine that represents a potential novel class of anticancer drugs targeting the 3' untranslated region of RNAs. Cordycepin has been reported to induce apoptosis in certain cancer cell lines, but the effects of cordycepin on human neuroblastoma cells have not been studied. In the present study, an MTT assay revealed that cordycepin inhibits the viability of neuroblastoma SK-N-SH and BE(2)-M17 cells in a dose-dependent manner. In addition, cordycepin increases the early-apoptotic cell population of SK-N-SH cells, as determined by fluorescence-activated cell sorting analysis. The induction of apoptosis in neuroblastoma cells by cordycepin was further confirmed by western blotting, which revealed cleavage of caspase-3 and poly(adenosine diphosphate-ribose) polymerase 1 in the SK-N-SH and BE(2)-M17 cells. Cordycepin also induced the formation of a punctate pattern of light-chain 3 (LC3)-associated green fluorescence in the SK-N-SH cells transfected with a pEGFP-LC3 vector. Furthermore, western blotting revealed cleavage of LC3 A/B in cordycepin-treated neuroblastoma SK-N-SH cells. Taken together, the results indicate that cordycepin significantly increases apoptosis and autophagy in neuroblastoma cells, and may therefore be a drug candidate for neuroblastoma therapy, but requires additional evaluation.

Citing Articles

Treatment with autophagic inhibitors enhances oligonol‑induced apoptotic effects in nasopharyngeal carcinoma cells.

Wu Y, Lin C, Chiu W, Hsieh T, Chang S, Chang Y Biomed Rep. 2024; 21(4):143.

PMID: 39161943 PMC: 11332131. DOI: 10.3892/br.2024.1831.


Glyceroglycolipids from the solid culture of strain LY34 isolated from Tibet of China.

Chen B, Lin J, Xu A, Yu D, Phurbu D, Dai H Mycology. 2022; 13(3):185-194.

PMID: 35938083 PMC: 9354630. DOI: 10.1080/21501203.2022.2036841.


A Systematic Review of the Biological Effects of Cordycepin.

Radhi M, Ashraf S, Lawrence S, Tranholm A, Wellham P, Hafeez A Molecules. 2021; 26(19).

PMID: 34641429 PMC: 8510467. DOI: 10.3390/molecules26195886.


The Role of Autophagy in Anti-Cancer and Health Promoting Effects of Cordycepin.

Chen Y, Chen C, Lin W, Tung C, Chen Y, Yang S Molecules. 2021; 26(16).

PMID: 34443541 PMC: 8400201. DOI: 10.3390/molecules26164954.


Novel formulation development from (Berk.) for management of high-altitude maladies.

Rakhee , Mishra J, Yadav R, Meena D, Arora R, Sharma R 3 Biotech. 2021; 11(1):9.

PMID: 33442508 PMC: 7778651. DOI: 10.1007/s13205-020-02536-3.


References
1.
Maris J . Recent advances in neuroblastoma. N Engl J Med. 2010; 362(23):2202-11. PMC: 3306838. DOI: 10.1056/NEJMra0804577. View

2.
Spix C, Pastore G, Sankila R, Stiller C, Steliarova-Foucher E . Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42(13):2081-91. DOI: 10.1016/j.ejca.2006.05.008. View

3.
Oh J, Baek Y, Kim S, Hwang H, Hwang H, Lee S . Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma (SKN-SH) cells induced by polysaccharides-peptide complexes produced by submerged mycelial culture of an entomopathogenic fungus Cordyceps sphecocephala. J Microbiol Biotechnol. 2008; 18(3):512-9. View

4.
Tuli H, Sharma A, Sandhu S, Kashyap D . Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 2013; 93(23):863-9. DOI: 10.1016/j.lfs.2013.09.030. View

5.
Gurney J, Ross J, Wall D, Bleyer W, Severson R, Robison L . Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol. 1997; 19(5):428-32. DOI: 10.1097/00043426-199709000-00004. View